Your browser doesn't support javascript.
loading
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT.
Shimoni, Avichai; Robin, Marie; Iacobelli, Simona; Beelen, Dietrich; Mufti, Ghulam J; Ciceri, Fabio; Bethge, Wolfgang; Volin, Liisa; Blaise, Didier; Ganser, Arnold; Luft, Thomas; Chevallier, Patrice; Schwerdtfeger, Rainer; Koster, Linda; de Witte, Theo; Kröger, Nicolaus; Nagler, Arnon; Yakoub-Agha, Ibrahim.
Afiliação
  • Shimoni A; Chaim Sheba Medical Center, Tel-Aviv University, Tel-Hashomer, Israel.
  • Robin M; Hematology/Transplantation, Saint Louis Hospital, Paris, France.
  • Iacobelli S; Interdipartimentale di Biostatistica e Bioinformatica, Universita tor Vergata, Rome, Italy.
  • Beelen D; Clinic for Bone Marrow Transplantation, University Hospital, Essen, Germany.
  • Mufti GJ; Haematological Medicine, King's College Hospital, London, United Kingdom.
  • Ciceri F; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute, Milano, Italy.
  • Bethge W; Department of Hematology, Oncology, Immunology, University of Tübingen, Tübingen, Germany.
  • Volin L; Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
  • Blaise D; Department of Hematology, Institut Paoli Calmettes, Marseille, France.
  • Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Luft T; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Chevallier P; Hematology Department, Nantes University Hospital, Nantes, France.
  • Schwerdtfeger R; Centre for Hematopoietic Cell Transplantation, German Diagnostic Clinic, Wiesbaden, Germany.
  • Koster L; EBMT Data Office, University Medical Centre, Leiden, Netherlands.
  • de Witte T; University Medical Centre St. Radboud, Nijmegen, Netherlands.
  • Kröger N; Department for Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Nagler A; Chaim Sheba Medical Center, Tel-Aviv University, Tel-Hashomer, Israel.
  • Yakoub-Agha I; CHU de Lille, INSERM U1286, Univ Lille, Lille, France.
Br J Haematol ; 195(3): 417-428, 2021 11.
Article em En | MEDLINE | ID: mdl-34514596
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Bussulfano / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Agonistas Mieloablativos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Bussulfano / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Agonistas Mieloablativos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Ano de publicação: 2021 Tipo de documento: Article